Plasminogen-activator Inhibitor 1 (PAI-1) participates in the occurrence and development of this state and is elevated in patients with type 2 diabetes, impaired glucose tolerance, and obesity. This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.